Biolegend, 108114, PE/Cyanine7 anti-mouse Ly-6A/E (Sca-1) Antibody, 100μg

Ly-6A/E, also known as Sca-1, is an 18 kD member of the Ly-6 multigene family. Ly6A/E is a glycosylphosphatidylinositol (GPI)-linked protein expressed on hematopoietic stem cells. In mice expressing the Ly-6.2 haplotype (e.g., AKR, C57BL, C57BR, DBA/2, SJL, SWR, and 129), Ly-6A/E is also expressed on peripheral B lymphocytes and thymic and peripheral T lymphocytes. Strains expressing the Ly-6.1 haplotype (e.g., BALB/c, CBA, C3H/He, DBA/1, and NZB) have low Ly-6A/E expression on resting peripheral lymphocytes. The expression of Ly-6A/E on lymphocytes is upregulated upon activation from both Ly6.1 and Ly6.2 haplotype mice. Ly-6A/E is thought to be involved in the regulation of both T and B cell responses.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: IL-2-dependent mouse T-cell line (CTL-L)
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The Ly-6A/E antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: The D7 antibody has been reported to induce T cell activation and inhibit TCR-induced IL-2 production. Additional reported applications (for the relevant formats) include: Western blotting1,2, immunoprecipitation1, in vitro lymphocyte activation3-6, induction of redirected lysis7, induction of T cell inhibitory signalling8, immunofluorescence9, and immunohistochemical staining of acetone-fixed frozen sections13 and Bouin-fixed, paraffin-embedded samples9. The two Sca-1 recognizing clones D7 and E13-161.7 have been shown to bind distinct epitopes due to the inability of D7 to block the binding of E13-161.7.14
Application References(PubMed link indicates BioLegend citation): Ortega G, et al. 1986. J. Immunol. 137:3240. (WB, IP) Palfree RGE, et al. 1986. Immunogenetics 23:197. (WB) Codias EK, et al. 1990. J. Immunol. 144:2197. Malek TR, et al. 1986. J. Exp. Med. 164:709. Codias EK, et al. 1990. J. Immunol. 145:1407. Ivanov V, et al. 1994. J. Immunol. 153:2394. Karlhofer FM, et al. 1991. J. Immunol. 146:3662. Fleming T, et al. 1994. J. Immunol. 153:1955. van Bragt MPA, et al. 2005. Biol. Reprod. 73:634. (IF, IHC) Umland O, et al. 2007. J. Immunol. 178:4147. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 45:149. (FC) PubMed Pronk CJ, et al. 2011. J. Exp Med. PubMed English A, et al. 2000. J. Immunol. 165:3763. (IHC) Bamezai A and Rock KL. 1995. Proc. Natl. Acad. Sci. USA 92:4294. Wiesner DL, et al. 2015. PLoS Pathog. 11:1004701. PubMed
Product Citations: Lang J, et al. 2020. Nat Commun. 11:1338. PubMed Hong X, et al. 2022. Cell Stem Cell. 29:1298. PubMed Pioli KT, et al. 2023. iScience. 26:106223. PubMed Bobadilla Muñoz M, et al. 2023. Front Cell Dev Biol. 11:1128534. PubMed Wu J, et al. 2022. Stem Cells Int. 2022:4249843. PubMed Wang D, et al. 2022. Cell Rep. 39:110587. PubMed Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed Moiseeva V, et al. 2023. Nature. 613:169. PubMed Huang D, et al. 2023. Exp Hematol Oncol. 12:11. PubMed Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed Domingues AF, et al. 2020. Elife. 9:e51754. PubMed Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed Hu X, et al. 2016. Nat Commun. 7:13095. PubMed Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed Hoffman D, et al. 2021. Immunity. 54:2712. PubMed Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed Beauchamp EM, et al. 2021. Blood Cancer Discov. 6:. PubMed Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed Arai F, et al. 2020. Cell Systems. 11(6):640-652.e5. PubMed Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed Ankawa R, et al. 2021. Developmental Cell. . PubMed Kim SP, et al. 2021. Cell Reports. 36(9):109626. PubMed Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed Solanas G, et al. 2017. Cell. 170:678. PubMed Gross ETE, et al. 2018. Oncoimmunology. 8:e1404212. PubMed Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed Yu VWC, et al. 2017. Cell. 168:944. PubMed Barman PK, et al. 2019. J Immunol. 202:2720. PubMed Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed Haase C, et al. 2022. Nat Methods. 19:1622. PubMed Kinkel SA, et al. 2022. iScience. 25:104684. PubMed Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed Telford W, et al. 2017. Cytometry A. 91:314. PubMed Dong S, et al. 2021. Nature. 591:117. PubMed Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed Chiba H, et al. 2013. Am J Physiol Cell Physiol. 305:693. PubMed Smith E, et al. 2009. J Immunol. 183:5685. PubMed García-Prat L, Muñoz-Cánoves P, Martínez-Vicente 2017. Muscle Stem Cells. 10.1007/978-1-4939-6771-1_14. PubMed Zaro BW, et al. 2020. eLife. 9:00. PubMed Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed Duan Y, et al. 2018. Stem Cells. 36:1430. PubMed Cho K, et al. 2021. iScience. 24:103117. PubMed Dagher T, et al. 2021. J Exp Med. 218:. PubMed Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed Gough D, et al. 2014. Blood. 124:2252. PubMed Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed Chen Z, et al. 2019. J Exp Med. 216:152. PubMed Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed Bota-Rabassedas N, et al. 2021. Cell Reports. 35(3):109009. PubMed Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed Nowlan B, et al. 2019. Haematologica. 105:71. PubMed Giraddi R, et al. 2015. Nat Commun. 6: 8487. PubMed Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed Wang S, et al. 2021. Commun Biol. 22:. PubMed Azazmeh N, et al. 2020. Nat Commun. 2.340972222. PubMed Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed Onai N, et al. 2020. Int J Mol Sci. :22. PubMed Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed Kang M, et al. 2021. Front Cell Dev Biol. 8:596622. PubMed Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed Liu F, et al. 2021. Cell Reports. 35(10):109225. PubMed Jin Y, et al. 2020. PeerJ. 8:e10374. PubMed Yosef R, et al. 2016. Nat Commun. 7: 11190. PubMed Christoforou N, et al. 2013. PLoS One. 8:65963. PubMed Zheng Z, et al. 2021. Nat Commun. 12:6202. PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed Yoshinaga M, et al. 2022. Nat Commun. 13:6435. PubMed Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed Iwanami N, et al. 2020. iScience. 23:101260. PubMed Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed Chavez JS, et al. 2022. Cells. 11:. PubMed Fielding C, et al. 2022. Nat Commun. 13:543. PubMed Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed Lerbs T, et al. 2020. JCI Insight. 5:00. PubMed Del Barco Barrantes I, et al. 2018. Stem Cell Reports. 10:257. PubMed Zhang B, et al. 2021. Nature. 599:471. PubMed Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed Youssif C, et al. 2018. EMBO Mol Med. 10:e8403. PubMed Hacein-Bey-Abina S, et al. 2020. Exp Hematol. 88:15. PubMed Man N, et al. 2021. JCI Insight. 6:. PubMed
RRID: AB_493597 (BioLegend Cat. No. 108113) AB_493596 (BioLegend Cat. No. 108114)
Structure: Ly-6 multigene family, 18 kD
Distribution: Hematopoietic stem cells, activated T cells and B cells, subset of resting B cells and T cells
Function: Regulates B and T cell responses
Cell Type: B cells, Hematopoietic stem and progenitors, Mesenchymal Stem Cells, T cells
Biology Area: Immunology, Stem Cells
Antigen References: 1. Rock KL, et al. 1989. Immunol. Rev. 111:195. 2. Morrison SJ, et al. 1994. Immunity 1:661. 3. Spangrude GJ, et al. 1988. J. Immunol. 141:3697. 4. Malek T, et al. 1986. J. Exp. Med. 164:709.
Gene ID: 110454
UniProt: View information about Ly-6A/E on UniProt.org
Clone: D7
Regulatory Status: RUO
Other Names: Sca-1
Isotype: Rat IgG2a, κ